Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

CPD modules

Sort by: Newest first Oldest first A-Z Z-A

  • Update on antiretroviral therapy Subscription

    In this article, Ms Elizabeth Davies provides an update on antiretroviral therapy (ART) by summarising recently revised British guidelines and discussing emerging toxicities, new therapies and treatment strategies for the future

  • Travel medicine (3) Food and water hygiene for the traveller Subscription

    This article, the third in our series about travel medicine, discusses the advice that can be given to travellers regarding safe food and water

  • Parkinson's disease: an overview Subscription

    PD is the second most common neurodegenerative disease experienced by man, Alzheimer’s disease being the most common. It affects 1 per cent of the population over 65 years of age, rising to 2 per cent over 80 years. It is estimated that 5 per cent of patients are diagnosed before their 40th year and that there are approximately 110,000 people with PD in the UK.

  • Parkinson's disease: treatment Subscription

    By David Burn, FRCP, MD

  • Multiple sclerosis: the disease and its treatment Subscription

    By Ahmed Toosy, MRCP, MA (Cantab) and Alan Thompson, FRCP, FRCPI

  • Alzheimer's disease Subscription

    In 1978, Lishman defined dementia as “an acquired global impairment of intellect, memory and personality but without impairment of consciousness.”1 Dementia is now more appropriately considered as a syndrome of acquired loss of cognitive function, behavioural changes and loss of social function.

  • Coeliac disease — a case study Subscription

    With the advent of more sensitive testing, it is estimated that the prevalence of coeliac disease has risen to as many as one in 300. Pharmacists need to have an appreciation of the difficulties faced by patients with coeliac disease and be able to offer good practical advice

  • Ehlers-Danlos

    Ever heard of Ehlers-Danlos syndrome? Subscription

    One in 5,000 people has Ehlers-Danlos syndrome — at least twice the number as have sickle cell anaemia, phenylketonuria or haemophilia A. Learn more about it here

  • Heart failure

    Heart failure: clinical features and diagnosis Subscription

    Around a third of patients diagnosed with heart failure will die within one year. Early identification of symptoms and diagnostic testing can lead to improved outcomes and better quality of life 

  • Old man walking

    Heart failure: management Subscription

    Reducing mortality and delaying disease progression are two key aims of treating heart failure but, for many patients, controlling symptoms and improving quality of life are more important than longevity

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.